Clinical Trial Update: Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Nivolumab to prevent colon adenomas in participants with Lynch syndrome and a history of partial colectomy. The study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenoma
• Colon Cancer
• Lynch Syndrome

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: John Hays | Conditions: Colon Adenoma, Colon Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-07-01